Onconetix (ONCO) Non Operating Interest Expenses (2023 - 2026)

Onconetix (ONCO) has reported Non Operating Interest Expenses for 4 consecutive years, with $4389.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Non Operating Interest Expenses fell 98.03% year-over-year to $4389.0 in Q2 2026; TTM through Jun 2026 was $310949.0, a 66.45% decrease from a year earlier, with the FY2025 full-year figure at $751005.0, down 14.02% from the prior year.
• Non Operating Interest Expenses was $4389.0 for Q2 2026 at Onconetix, up from $2244.0 in the prior quarter.
• Over five years, Non Operating Interest Expenses peaked at $300069.0 in Q3 2025 and troughed at $2244.0 in Q1 2026.
• A 4-year average of $177108.2 and a median of $213996.0 in 2023 frame the typical range for Non Operating Interest Expenses.
• Across the five-year window, Non Operating Interest Expenses surged 31.73% in 2024 and sank 99.0% in 2026, its largest moves.
• Over 4 years, Non Operating Interest Expenses stood at $188532.0 in 2023, then surged by 31.73% to $248349.0 in 2024, then slumped by 98.29% to $4247.0 in 2025, then advanced by 3.34% to $4389.0 in 2026.
• The last three Non Operating Interest Expenses figures came in at $4389.0 (Q2 2026), $2244.0 (Q1 2026), and $4247.0 (Q4 2025), per Business Quant data.